XEGEMDI Trademark

Trademark Overview


On Friday, March 12, 2021, a trademark application was filed for XEGEMDI with the United States Patent and Trademark Office. The USPTO has given the XEGEMDI trademark a serial number of 79311364. The federal status of this trademark filing is REGISTERED as of Tuesday, September 28, 2021. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The XEGEMDI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoim...
xegemdi

General Information


Serial Number79311364
Word MarkXEGEMDI
Filing DateFriday, March 12, 2021
Status700 - REGISTERED
Status DateTuesday, September 28, 2021
Registration Number6495836
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 13, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Saturday, December 25, 2021NOTIFICATION PROCESSED BY IB
Monday, December 6, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 6, 2021FINAL DISPOSITION PROCESSED
Thursday, October 28, 2021GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, July 13, 2021PUBLISHED FOR OPPOSITION
Wednesday, June 23, 2021NOTICE OF PUBLICATION
Friday, June 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Tuesday, June 1, 2021APPLICATION FILING RECEIPT MAILED
Wednesday, May 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 25, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 20, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB